Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Preferred Stock Liabilities (2024 - 2025)

Carlsmed's Preferred Stock Liabilities history spans 2 years, with the latest figure at $65.4 million for Q2 2025.

  • For Q2 2025, Preferred Stock Liabilities rose 381.29% year-over-year to $65.4 million; the TTM value through Jun 2025 reached $65.4 million, up 381.29%, while the annual FY2024 figure was $29.8 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $65.4 million in Q2 2025 per CARL's latest filing, up from $29.8 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $65.4 million in Q2 2025 to a low of $13.6 million in Q2 2024.